Et al Phillip Frost MD - 19 Mar 2025 Form 4/A - Amendment Insider Report for Fluent, Inc. (FLNT)

Role
10%+ Owner
Signature
/s/ Dr. Phillip Frost, M.D., Trustee
Issuer symbol
FLNT
Transactions as of
19 Mar 2025
Net transactions value
+$1,999,999
Form type
4/A - Amendment
Filing time
27 Mar 2025, 12:05:45 UTC
Date Of Original Report
21 Mar 2025
Previous filing
17 Mar 2025
Next filing
28 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLNT Common Stock Options Exercise $230 +459,981 +11% $0.000500 4,838,037 20 Mar 2025 Held by Frost Gamma Investments Trust F1
transaction FLNT Common Stock Tax liability $228 -112 -0% $2.04 4,837,925 20 Mar 2025 Held by Frost Gamma Investments Trust F1
holding FLNT Common Stock 8,334 19 Mar 2025 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLNT Pre-Funded Warrants Award $999,999 +459,981 $2.17 459,981 19 Mar 2025 Common Stock 459,981 $0.000500 Held by Frost Gamma Investments Trust F1, F2
transaction FLNT Pre-Funded Warrants Options Exercise $999,999 +459,981 $2.17 459,981 20 Mar 2025 Common Stock 459,981 $0.000500 Held by Frost Gamma Investments Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 The Pre-Funded Warrants terminate when exercised in full.
F3 The Pre-Funded Warrants were immediately exercisable when issued. The Pre-Funded Warrants were exercised on March 20, 2025.
F4 The Reporting Person owns 8,334 shares of Common Stock which were inadvertently left off the Form 4 filed March 21, 2025.